UNSPSC 85602318: Supplement descending colon with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement descending colon with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DUM47Z

UNSPSC 85602318 Supplement descending colon with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not reflect the scope of state and local procurement activity currently being tagged under it. The recent opportunities show no medical device or tissue-substitute procurement; instead, they center on health-plan administration, occupational medical surveillance, pharmacy benefit management, temporary clinical staffing, and disability medical evaluation services—none of which align with the code's nominal orthopedic-surgical-device scope. The issuing bodies include city and county health authorities, retirement offices, and state transportation agencies procuring administrative and professional medical services rather than medical devices or surgical materials. This mismatch indicates the code is being applied inconsistently or the source opportunities are mislabeled.

The geographic spread includes Arizona (City of Phoenix Retirement Office, independent medical evaluation services), California (City of Long Beach health-plan carve-out, County of Santa Clara temporary health professional staffing), Washington (Washington State Department of Transportation occupational medical surveillance), Florida (Collier County pharmacy benefit management), and Texas (Harris County Juvenile Probation Department specialty medical services). The most recent solicitations are the Washington State Department of Transportation occupational medical surveillance RFP (due October 9, 2026), the City of Long Beach surgical benefit carve-out RFP (due October 7, 2026), and the City of Phoenix independent medical evaluation RFP (due October 16, 2026). No procurement activity related to the code's stated product category—autologous tissue substitutes for endoscopic spinal procedures—appears in the record.